“Understanding Richter transformation is one of the biggest unmet needs for patients with chronic lymphocytic leukemia,” says our Dr. William Wierda.
Learn more: https://t.co/KW93JbxHk5 @wwierda#leukemia#EndCancer
@davidcnorrismd @iwCLL @anthonymatomd @tobyeyre82@DrMDavids@sparikhmd@wwierda The trial did not report on the dose reductions and relation to outcomes. This data shows that some pts can remain progression free for sometime after stopping ibrutinib. I won’t recommend this strategy outside of a trial.
Great discussion with Lydia Scarfo at iwCLL 2019, Edinburgh. With different standard options, I think we all agree that the future is combined targeted treatment and MRD is important endpoint!
Dr. Philip Thompson speaking this morning at the CLL Patient and Caregiver Educational Forum at MDACC. Great presentation on diagnosing CLL, prognostic factors and first-line treatment.
#ASH2018 @anthonymatomd @DrMDavids@OncLive Great ASH2018 CLL summary and discussion with my CLL colleagues on OncLive Peer Exchange. Stay tuned for the link to view!!!
Register now for the 2018 Greater Houston Women's Chamber of Commerce Hall of Fame Gala. Join us for an evening that will include a reception, silent auction, dinner and program. #GHWCC#oncsurgery